Torrent Pharmaceuticals announced Q2FY23 results: Revenue at Rs 2,291 crore up by 7%. Gross margins: 72%; EBITDA margins: 30%. EBITDA at Rs 694 crore was down by 2%. Net profit after tax at Rs 312 crore was down by 1%. Result PDF
Conference Call with Torrent Pharmaceuticals Management and Analysts on its acquisition of Curatio Healthcare. Listen to the full transcript.